Alexion Pharma (ALXN), Halozyme (HALO) Enter License Agreement for ENHANZE Technology
Tweet Send to a Friend
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today a collaboration and license agreement that enables ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
